oral propranolol for treatment of pediatric hemangioma (long-term follow-up)
Authors
abstract
purpose: to assess the effect and long-term results of oral propranolol in pediatric capillary hemangiomas. methods: four children aged 3 months to 5 years with periocular and orbital hemangioma of infancy (hoi) were treated with propranolol, 2 milligram per kilogram per day divided in 2 doses. propranolol was continued in all cases until the end of the first year of life and tapered over 2-3 weeks. results: significant improvement was noted in all patients in the first 2 months of treatment and continued slowly during the follow-up. no serious complications were observed during the follow-up period. conclusion: oral propranolol can be used as the first line treatment in children with capillary hemangioma.
similar resources
A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...
full textA 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...
full textA 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol
Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangioma treating in children. A randomized, open label crossover trial with two twenty four-week trea...
full textLong-term follow-up care for pediatric cancer survivors.
Progress in therapy has made survival into adulthood a reality for most children, adolescents, and young adults diagnosed with cancer today. Notably, this growing population remains vulnerable to a variety of long-term therapy-related sequelae. Systematic ongoing follow-up of these patients, therefore, is important for providing for early detection of and intervention for potentially serious la...
full textOral Propranolol: A Useful Treatment for Infantile Hemangioma
Background: Infantile haemangioma is the commonest childhood tumor. Several lines of treatment are available. Recent reports have focused on the value of propranolol in treating rapidly proliferating haemangioma. The aim of this study was to assess oral propranolol in treatment for facial haemangioma. Patients and Methods: Fifteen patients with rapidly proliferating infantile facial haemangioma...
full textOral Propranolol for Circumscribed Choroidal Hemangioma
INTRODUCTION Several therapeutic approaches have been developed to treat choroidal hemangioma. However, all these therapies are associated with a potential risk of damaging the overlying retina. CASE REPORT We report a case of circumscribed choroidal hemangioma (CCH) in a 59-year-old man refractory to laser treatment. Visual acuity was 20/200 and a serous macular detachment was present. The C...
full textMy Resources
Save resource for easier access later
Journal title:
بیناجلد ۱۷، شماره ۴، صفحات ۳۶۳-۳۶۸
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023